Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
FGF-dependent regulation of VEGF receptor 2 expression in mice
Masahiro Murakami, … , Brian L. Black, Michael Simons
Masahiro Murakami, … , Brian L. Black, Michael Simons
Published June 1, 2011
Citation Information: J Clin Invest. 2011;121(7):2668-2678. https://doi.org/10.1172/JCI44762.
View: Text | PDF
Research Article Vascular biology

FGF-dependent regulation of VEGF receptor 2 expression in mice

  • Text
  • PDF
Abstract

Numerous studies have suggested a link between the angiogenic FGF and VEGF signaling pathways; however, the nature of this link has not been established. To evaluate this relationship, we investigated VEGF signaling in ECs with disrupted FGF signaling in vitro and in vivo. ECs lacking FGF signaling became unresponsive to VEGF, caused by downregulation of VEGF receptor 2 (VEGFR2) expression after reduced Vegfr2 enhancer activation. FGF mediated VEGFR2 expression via activation of Erk1/2. Transcriptional analysis revealed that Ets transcription factors controlled VEGFR2 expression in an FGF- and Erk1/2-dependent manner. Mice with defective FGF signaling exhibited loss of vascular integrity and reduced vascular morphogenesis. Thus, basal FGF stimulation of the endothelium is required for maintenance of VEGFR2 expression and the ability to respond to VEGF stimulation and accounts for the hierarchic control of vascular formation by FGFs and VEGF.

Authors

Masahiro Murakami, Loc T. Nguyen, Kunihiko Hatanaka, William Schachterle, Pei-Yu Chen, Zhen W. Zhuang, Brian L. Black, Michael Simons

×

Figure 3

FGF signaling controls VEGF-induced angiogenesis.

Options: View larger image (or click on image) Download as PowerPoint
FGF signaling controls VEGF-induced angiogenesis.
(A and B) Quantitative...
(A and B) Quantitative real-time PCR analysis of Vegfr2 (A) and Vegfr1 (B) mRNA expression in adductor muscle. Total RNA was isolated from muscle tissues of C57BL/6 mice injected with Ad-Null or Ad–sFGFR1-IIIc (5 × 1010 viral particles) harvested 7 days after Ad injection (n = 3 per group). (C) Matrigel plugs, mixed with either FGF2 or VEGF-A, were placed subcutaneously in C57BL/6 mice injected with Ad-Null or Ad–sFGFR1-IIIc 7 days before plug implantation. (D) Quantitative analysis of Matrigel plug assay. Sections of Matrigel plugs were stained for CD31, and the number of vessels was counted (n = 3 per group). (E) Ad–Flag-VEGFR2 was mixed with Matrigel prior to injection in the mouse, and the section of the Matrigel was subjected to immunohistochemical evaluation of exogenous VEGFR2 expression using anti-Flag antibody. Scale bars: 20 μm. (F) Quantitative analysis of in vivo Matrigel plug assay (n = 3 per group). (G) Quantitative analysis of in vivo Matrigel plug assay (n = 3 per group). Mice received Matrigel supplemented with VEGF-A plus Ad–ME-LA showed increased vessel formation in the absence of FGF signaling. *P < 0.05 versus respective control or as indicated by brackets.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts